Kyowa Kirin Co Ltd
DUS:KY4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kyowa Kirin Co Ltd
DUS:KY4
|
JP |
|
Mitra Adiperkasa Tbk PT
IDX:MAPI
|
ID |
|
A
|
American Films Inc
OTC:AMFL
|
US |
|
E
|
Enel SpA
F:ENL
|
IT |
Intrinsic Value
Is KY4 undervalued or overvalued?
See the intrinsic value estimate for 
Kyowa Kirin Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
KY4 looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with KY4’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Kyowa Kirin Does
Kyowa Kirin is a Japanese pharmaceutical company that develops, makes, and sells prescription medicines. Its main business is creating drugs for serious conditions such as blood disorders, kidney-related diseases, and rare diseases, then bringing those medicines to hospitals and specialists who treat those patients. It also works on research and development, which is the starting point for its future drug pipeline.
- Headquarters
- Japan JP
- Employees
- 5 161
- IPO date
- Aug 22, 1949
Revenue & Expenses Breakdown
Kyowa Kirin Co Ltd
Earnings Waterfall
Kyowa Kirin Co Ltd
The intrinsic value for Kyowa Kirin Co Ltd (KY4) under the Base Case is hidden EUR.
Compared with the current market price of 13.4 EUR, the stock appears hidden.